A team of United States-based scientists recently conducted a study to evaluate the effect of Mycobacterium tuberculosis infection on the pathogenesis of severe acute respiratory syndrome coronavirus ...

MicuRx Pharmaceuticals, Inc. ('MicuRx'), a clinical-stage biopharmaceutical company focused on developing novel anti-infective therapies for drug-resistant bacterial infections, recently announced ...

Mycobacterium tuberculosis, the causative agent of the respiratory disease tuberculosis, caused 1.6 million deaths in 2021. Tuberculosis, despite being preventable and curable, is responsible for the ...

The number of reported cases using viruses to treat deadly Mycobacterium infections just went up by a factor of five. Researchers report 20 new case studies on the use of the experimental treatment, ...

Tuberculosis (TB) is a serious infectious disease caused by the bacterium Mycobacterium tuberculosis. While multidrug treatment regimens are the standard of care, the lengthy treatment schedule and ...

Scientists from the University of Cape Town's (UCT) Institute of Infectious Disease and Molecular Medicine (IDM) have contributed to an international study that shed new light on why humans and ...

Mycobacterium abscessus (MAB) is a species of nontuberculous mycobacteria (NTM) and a major causative pathogen of pulmonary diseases especially in patients with cystic fibrosis. MAB infection is ...

Nontuberculous mycobacteria (NTM) are known as atypical mycobacteria. That means they’re related to tuberculosis, but they don’t cause the same disease. In fact, NTM are generally harmless. That’s a ...

Mycobacterium avium complex (MAC), a type of nontuberculous mycobacteria (NTM), lives all around us. You’ll find these germs in dirt, dust, and drinking water. They’re also common in natural sources ...